Faculty Information - HASHIMOTO Yaichiro

■ Published papers

1.	Case report	A long-term survival case of bladder cancer with distant metastases: abscopal effect of brain metastases after stereotactic radiotherapy with immune checkpoint blockade therapy to lung metastases 2023/03/25
2.	Original article	Relationship between changes in quality of life and genitourinary toxicity grade after brachytherapy with I-125 alone for localised prostate cancer 2023/03/15
3.	Original article	Predictors of Adverse Gastrointestinal Events After Stereotactic Body Radiation Therapy for Liver Tumors 2023/01
4.	Case report	Cardiac metastasis after esophagogastrectomy for esophageal adenocarcinoma with an antemortem diagnosis. 2022/02
5.	Original article	Study of feasible and safe condition for total body irradiation using cardiac implantable electronic devices 2021/09/20
6.	Case report	Abscopal complete regression of hepatocellular carcinoma with multiple pleural metastases. 2021/01
7.	Original article	Prediction of radiation‐induced malfunction for cardiac implantable electronic devices (CIEDs) 2020/02/21
8.	Original article	Efficacy and feasibility of low-dose rate brachytherapy for prostate cancer in renal transplant recipients. 2016/04/01
9.	Original article	Nationwide multi-institutional retrospective analysis of high-dose-rate brachytherapy combined with external beam radiotherapy for localized prostate cancer: An Asian Prostate HDR-BT Consortium 2017/05
10.	Case report	Intensity-modulated radiation therapy for small cell carcinoma of the prostate: A case report 2017/09/01
11.	Original article	The 5-year outcomes of moderately hypofractionated radiotherapy (66Gy in 22 fractions, 3 fractions per week) for localized prostate cancer: a retrospective study 2017/07
12.	Original article	Chemoradiotherapy for solitary lymph node metastasis after curative resection of esophageal cancer 2016/08
13.	Review article	Current Status of High Precision Radiotherapy 2018/06
14.	Case report	Efficacy and Feasibility of Intensity-Modulated Radiation Therapy for Prostate Cancer in Renal Transplant Recipients 2016/04/01
15.	Original article	Correlation between the changes in the EPIC QOL scores and the dose-volume histogram parameters in high-dose-rate brachytherapy combined with hypofractionated external radiation therapy for prostate cancer 2015
16.	Case report	A case report of radiotherapy for adenosquamous carcinoma of the pancreas 2014/09
17.	Case report	Dropped Head Syndrome Induced by Chemoradiotherapy for Nasopharyngeal Carcinoma: A Case Report. 2012/08
18.	Original article	Accuracy of PET for Diagnosis of Solid Pulmonary Lesions with18F-FDG UptakeBelow the Standardized Uptake Value of 2.5 2006/03
Display 5 items
Display all(18)

■ Academic conference presentation

1.	Long term results of radiation therapy in stage I thoracic esophagus squamou s cell carcinoma 2023/11/30
2.	Salvage Radiotherapy for Recurrent Malignant Brain Tumors: Safety and Efficacy Findings from a Retrospective Analysis. 2023/09/15
3.	Predictors of Adverse Gastrointestinal Events After Stereotactic Body Radiation Therapy for Liver Tumors 2022/11/12
4.	Combining C-ion irradiation and PARP inhibitor, Olaparib efficiently kills B RCA1 mutated TNBC cells 2022/11/11
5.	Clinical investigation of the usefulness of hypofractionated radiotherapy for malignant glioma 2022/04/16
6.	Initial experience of stereotactic body radiotherapy (SBRT) for metastatic bone tumors in our hospital 2021/11/12
7.	Numerical study of linear relationship between neutron dose and risk to cardiac implantable electronic devices in radiotherapy 2020/05/15
8.	Correlation between the changes in the EPIC QOL score and the grading of genitourinary toxicity after permanent prostate brachytherapy with I-125 alone for prostate cancer 2019/10/25
9.	Prostate imaging reporting and data system score before prostate biopsy can predict biochemical recurrence in patients with prostate cancer treated with radiotherapy. 2019/05/06
10.	High dose rate brachytherapy with hypofractionated external beam radiotherapy for high-risk prostate cancer 2017/09/25
11.	The 5-year outcomes of moderately hypofractionated radiotherapy for localized prostate cancer. 2017/09/25
12.	“High dose rate brachytherapy with hypofractionated external beam radiotherapy for high-risk prostate cancer” 2017/09
13.	Usefulness of multiparametric MRI in prognosis for high risk prostate cancer after radiotherapy. 2017/04/21
14.	Acute toxicity evaluation of adjuvant hypofractionated radiotherapy after cryotherapy for early breast cancer. 2017/04/13
15.	The efficacy and toxicity of radiotherapy with S-1 for localized pancreatic cancer 2016/09
16.	Radiation Therapy for Esophageal Cancer in Japan 2016/08/27
17.	Postoperative radiotherapy for patients with malignant parotid tumor 2016/04/16
18.	Outcome and toxicities of high-dose rate brachytherapy combined with hypofractionated external beam radiation therapy for high-risk prostate cancer 2016/04
19.	Radiotherapy for Solitary Lymph Node Metastasis after Curative Resection of Esophageal Cancer 2015/11/19
20.	Efficacy and feasibility of intensity-modulated radiation therapy for prostate cancer in renal-transplant recipients. 2015/08/26
21.	Efficacy and feasibility of low-dose brachytherapy for prostate cancer in renal-transplant recipients. 2015/08/26
22.	Radiontherapy for Lymphnode metastasis after curative resection of esophageal cancer 2015/04/17
23.	Hypofractionated image guided-IMRT for clinically localized prostate cancer. 2014/09/14
24.	Outcomes and Failure Patterns of Oropharyngeal Cancer treated with Simultaneous Integrated Boost-Intensity Modulated Radiation Therapy (SIB-IMRT). 2014/05
25.	Outcomes and Failure Patterns of Oropharyngeal Cancer treated with Simultaneous Integrated Boost-Intensity Modulated Radiation Therapy (SIB-IMRT). 2013/10
26.	Outcomes and Failure Patterns of Oropharyngeal Cancer treated with Simultaneous Integrated Boost-Intensity Modulated Radiation Therapy (SIB-IMRT) 2013/04/13
27.	Correlation between the Changes in the EPIC QOL Score and the DVH Parameters in High Dose Rate Brachytherapy combined with Hypofractionated EBRT for Prostate Cancer 2011/10/02
28.	Acute and late toxicity after hypofractionated intensity-modulated radiotherapy for localized prostate cancer [Poster Presentations] 2010/11
29.	Correlation between the changes in the Epic QOL score and the severity of acute genitourinary toxicity after permanent brachytherapy with I-125 alone for prostate cancer [Poster Presentations] 2010/11
30.	Acute Genitourinary Toxicity after Real-time Planning High Dose Rate (HDR) Brachytherapy for Prostate Cancer: Comparison of the Incidence of Grade 2 or Worse Acute GU Toxicity between Intra-operative Real-time and Post-operative CT-based Planning. 2008/09/21
31.	Outcome of breast-conserving therapy at Tokyo Women's Medical University Hospital 2007/11/18
32.	Accuracy of PET for Diagnosis of Solid Pulmonary Lesions with 18F-FDG Uptake Below the Standerdized Uptake Value of 2.5 2005/05/03
Display 5 items
Display all(32)

■ Research areas

Radiological sciences

■ Awards & honors

1.	2015/05	Excellent Poster Award
2.	2015/05	Young Investigators Travel Award

■ Academic society memberships

1.	2003/11～	Japan Radiological Society (JRS)
2.	2005/05～	Japanese Society for Therapeutic Radiology and Oncology (JASTRO)
3.	2005/06～	Japan Society of Clinical Oncology
4.	2006/07～	Japanese Radiation Oncology Study Group (JROSG)
5.	2011/11～	Radiation Oncology Conference
6.	2013/01～	Japanese Prostate Permanent Seed Implantation Study Group
7.	2018/11～2021/01	Japanese Association for Medical Artificial Intelligence
Display 5 items
Display all(7)

■ Education

1.

1996/04～2002/03

School of Medicine, Faculty of Medicine, Hiroshima University, Graduated

■ Academic & professional experience

1.	2009/04～2016/04	Assistant Professor
2.	2004/06～2009/04	Assistant Professor
3.	2019/01～	Head
4.	2016/05～	Head

■ Rsearch funding number

20385420